Thibaut De Smedt

Thibaut is a Venture Partner in the Medicxi investment team. Prior to joining Medicxi, Thibaut co-founded three early-stage biotechnology companies (AiDD, Immuthes and xSeedD). He was previously Research Director at Addex Therapeutics (focused on allosteric drug development), Senior Group Leader at Apoxis (a spinout from the University of Lausanne) and Research Scientist at Amgen (developing therapies for cancer and inflammation).  

Thibaut received a PhD in Molecular Biology and Immunology from the Université Libre de Bruxelles, Belgium and conducted postdoctoral research at Immunex in Seattle, USA. He is currently managing director at Immuthes and xSeedD.